Solel Partners LP Has $74.66 Million Stake in Humana Inc. (NYSE:HUM)

Solel Partners LP boosted its position in Humana Inc. (NYSE:HUM) by 48.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 199,800 shares of the insurance provider’s stock after acquiring an additional 65,000 shares during the period. Humana accounts for 12.2% of Solel Partners LP’s portfolio, making the stock its largest position. Solel Partners LP’s holdings in Humana were worth $74,655,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HUM. CarsonAllaria Wealth Management Ltd. raised its position in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in shares of Humana during the second quarter worth $35,000. Family Firm Inc. bought a new stake in Humana in the second quarter valued at about $37,000. Hollencrest Capital Management acquired a new position in Humana in the second quarter valued at about $40,000. Finally, Riverview Trust Co bought a new position in Humana during the second quarter worth about $44,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of recent analyst reports. Piper Sandler started coverage on Humana in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price target for the company. Oppenheimer upped their target price on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. TD Cowen increased their target price on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. JPMorgan Chase & Co. boosted their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Finally, Robert W. Baird began coverage on Humana in a research note on Thursday, May 30th. They set a “neutral” rating and a $374.00 price objective on the stock. Thirteen research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus target price of $398.70.

Humana Trading Up 0.8 %

Shares of NYSE:HUM opened at $312.74 on Tuesday. The stock has a market capitalization of $37.69 billion, a PE ratio of 19.47, a price-to-earnings-growth ratio of 2.56 and a beta of 0.50. The company’s 50-day moving average price is $356.28 and its two-hundred day moving average price is $345.36. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. Humana Inc. has a one year low of $298.61 and a one year high of $530.54.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $8.94 earnings per share. On average, equities analysts forecast that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a yield of 1.13%. Humana’s payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.